Phenomix Sciences is a precision medicine obesity biotechnology pioneer on a mission to conquer obesity globally through the science of phenotyping, the understanding of how genes combined with environmental and behavioral factors can inform obesity treatment plans. Mayo Clinic physicians, scientists, and researchers, Drs. Acosta and Camilleri, founded the company under the belief that the key to understanding obesity is unprecedented access to its clinical and molecular information throughout all stages and phenotypes of the disease.  Phenomix leverages data intelligence to yield better accuracy in predicting individual patient response to specific weight loss interventions and reducing the variability in weight loss results for patients. 

Securian Financial Group

Phenomix Sciences

Phenomix Sciences is a precision health company that leverages advanced metabolic phenotyping to provide personalized health insights. The company's technology platform is designed to analyze individuals' metabolic data to inform tailored nutrition and health interventions.

COM:PHENOMIXSCIENCES

Phenomix Sciences

Filings Not Available